Our Unique Approach
Since the beginning, we have been focused on developing partnerships with elite academic institutions, medical societies, and advocacy groups to develop our products. Generating high-quality clinical evidence represents our enduring commitment to cancer care, while ensuring access and resources for patients and their caregivers is at the heart of everything we do.
Our Shared Future
|Genomic Intelligence||Enhanced Experiences||Trusted Partner|
|Our Commitment to You||Help you apply advanced genomic science to reveal the unique biology of each patient’s condition.||Deliver exceptional user experience while continually advancing tests that are easy to interpret.||Serve as an innovator in cancer diagnostics, predicting and solving the latest problems in oncology.|
|Benefits of Our Tests||
Apply personalized insights for greater confidence in treatment decisions.
Receive timely, accurate results for faster decisions.
Inform treatment decisions before, during, and after treatment with therapy selection and recurrence risk genomic information.
Enable an efficient ordering and result-gathering process with a convenient physician portal.
Use interactive report guides and easy-to-read results to make informed decisions.
Provide patients with important billing and coverage information, along with access to results and ordering details all in one place.
Testing options across the stages of cancer care, from diagnosis through progression or remission.
Shared confidence through exemplary Oncotype DX® tests with strong supporting evidence and proven clinical utility.
Feel confident using tests with over 1.5M patients tested and our ongoing commitment to provide patients the information they need to make treatment decisions.